Distinguished in Gitelman Syndrome

Limeng Z. Chen

State Key Laboratory Of Complex Severe And Rare Diseases
Beijing, CN 
Distinguished in Gitelman Syndrome
State Key Laboratory Of Complex Severe And Rare Diseases
Beijing, CN 
OverviewLocationsClinical Research

Overview

Limeng Chen practices in Beijing, China. Chen is rated as a Distinguished expert by MediFind in the treatment of Gitelman Syndrome. Their top areas of expertise are Aminoaciduria, Gitelman Syndrome, Renal Glycosuria, Fanconi Bickel Syndrome, and Kidney Transplant.

Their clinical research consists of co-authoring 95 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 8 articles in the study of Gitelman Syndrome.

Locations

State Key Laboratory of Complex Severe and Rare Diseases
Beijing, China
Other Locations
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Study of Efficacy and Safety of Automated Peritoneal Dialysis in Urgent Start Dialysis as Compared With Intermittent Hemodialysis in ESRD Patients,a Multi-center, Non-blind and Controlled Clinical Trial
The Study of Efficacy and Safety of Automated Peritoneal Dialysis in Urgent Start Dialysis as Compared With Intermittent Hemodialysis in ESRD Patients,a Multi-center, Non-blind and Controlled Clinical Trial
Enrollment Status: Terminated
Publish Date: June 08, 2025
Intervention Type: Procedure
Study Phase: Not Applicable

95 Total Publications

A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury.
A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury.
Journal: Epigenetics
Published: October 07, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile